The rising cost of healthcare is being driven in part by aging populations around the world and the growing incidence of chronic diseases. Some argue that the only way we will reign in cost is through innovation rather than cost cutting care. We spoke to Gil Van Bokkelen, chairman of the Alliance for Regenerative Medicine and Chairman and CEO of Athersys, about the role regenerative medicine can play in addressing these problems, the landscape today, and the challenges these companies face in funding innovative therapies in the current environment.

The Burrill Report (January 17, 2012): Why Regenerative Medicine Might Fix Healthcare (.MP3,17.59 Mb)